These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17523434)

  • 1. [Anti-infectious defense of vagina during use of low-dose monophasic contraceptives].
    Lebedeva OP; Kalutskiĭ PV
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (1):67-70. PubMed ID: 17523434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on candidal vaginitis. Vaginal pH, microbiology, and cytology.
    Peeters F; Snauwaert R; Segers J; Amery W; van Cutsem J
    Am J Obstet Gynecol; 1972 Jan; 112(1):80-6. PubMed ID: 4621407
    [No Abstract]   [Full Text] [Related]  

  • 3. [Isolation of Candida. Value of various methods with special reference to rehydrated test strips].
    Schurz AR; Breitfellner G; Kiesler J
    Gynakol Rundsch; 1980 Jun; 20 Suppl 2():279-80. PubMed ID: 7194292
    [No Abstract]   [Full Text] [Related]  

  • 4. Local Th1/Th2 cytokine production during experimental vaginal candidiasis: potential importance of transforming growth factor-beta.
    Taylor BN; Saavedra M; Fidel PL
    Med Mycol; 2000 Dec; 38(6):419-31. PubMed ID: 11204879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Colpocytology in patients on hormonal contraceptives].
    Struzziero E; Corbo M
    Minerva Ginecol; 1996 Mar; 48(3):93-4. PubMed ID: 8684693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of contraceptive methods on the onset of symptomatic vulvovaginal candidiasis within the menstrual cycle.
    Nelson AL
    Am J Obstet Gynecol; 1997 Jun; 176(6):1376-80. PubMed ID: 9215201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonbarrier contraceptives and vaginitis and vaginosis.
    Roy S
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1240-4. PubMed ID: 1951581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of vaginal secretory IgA in subjects with vaginitis caused by a mixed "coccacea" flora].
    Cifarelli F; Paparo BS; Sanguigni S; Clemente M; Bianculli C
    Ann Sclavo; 1980; 22(4):690-3. PubMed ID: 7247506
    [No Abstract]   [Full Text] [Related]  

  • 9. Abnormal vaginal microbioma is associated with severity of localized provoked vulvodynia. Role of aerobic vaginitis and Candida in the pathogenesis of vulvodynia.
    Donders GGG; Bellen G; Ruban KS
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1679-1685. PubMed ID: 29934834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulvovaginal candidosis and oral contraceptives.
    Pumpianski R; Ganor S
    Mykosen; 1974 Aug; 17(8):173-8. PubMed ID: 4610385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral progestational agents as a cause of Candida vaginitis.
    Walsh H; Hildebrandt RJ; Prystowsky H
    Am J Obstet Gynecol; 1968 Aug; 101(7):991-3. PubMed ID: 5659957
    [No Abstract]   [Full Text] [Related]  

  • 12. Candida precipitins in pregnant women: validity of the test systems used.
    Stanley VC; Hurley R
    J Clin Pathol; 1974 Jan; 27(1):66-9. PubMed ID: 4595207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis.
    De Bernardis F; Lucciarini R; Boccanera M; Amantini C; Arancia S; Morrone S; Mosca M; Cassone A; Santoni G
    Infect Immun; 2006 Jul; 74(7):4282-94. PubMed ID: 16790803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral and vaginal Candida colonization under the influence of hormonal contraception (author's transl)].
    Klinger G; Tiller FW; Klinger G
    Zahn Mund Kieferheilkd Zentralbl; 1982; 70(2):120-5. PubMed ID: 6211864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of mono- and biphasic oral contraceptives on colpitis of various etiologies].
    Mettler L; Luh W; Anger H
    Z Geburtshilfe Gynakol; 1970; 173():168-80. PubMed ID: 12255191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of hormonal contraceptives on the incidence of mycotic vulvovaginitis].
    Sitek T; Merkel M; Pisarek-Miedzińska D
    Ginekol Pol; 1984 Sep; 55(9):669-73. PubMed ID: 6534812
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies to Candida albicans in human cervicovaginal secretions.
    Milne JD; Warnock DW
    Br J Vener Dis; 1977 Dec; 53(6):375-8. PubMed ID: 342069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis.
    Giraldo P; von Nowaskonski A; Gomes FA; Linhares I; Neves NA; Witkin SS
    Obstet Gynecol; 2000 Mar; 95(3):413-6. PubMed ID: 10711554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
    Maraki S; Mavromanolaki VE; Stafylaki D; Nioti E; Hamilos G; Kasimati A
    Mycoses; 2019 Aug; 62(8):692-697. PubMed ID: 31132175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the bacterial flora associated with vaginitis caused by Candida albicans].
    Selvaggi L; Restaino A; Loizzi P; Causio F; Mollica G
    Minerva Ginecol; 1981 Sep; 33(9):863-6. PubMed ID: 7322431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.